Home » Topics » Respiratory, BioWorld Science

Respiratory, BioWorld Science
RSS

Dura submits NDA for Albuterol Spiros

Nov. 12, 1997

Zeneca selects new HLE inhibitor for clinical development

Nov. 6, 1997

Chiroscience develops new TNF/PDE IV inhibitors

Nov. 4, 1997

HMR claims dual H1/NK1 antagonists for allergic/inflammatory disorders

Nov. 4, 1997

rPAF-AH proceeds to phase II for asthma

Oct. 31, 1997

HMR reports dual H1/NK1 receptor antagonists

Oct. 30, 1997

Spotlight on tryptase inhibitors for asthma

Oct. 28, 1997

SciClone presents promising preclinical data for CPX at CF conference

Oct. 27, 1997

Potent, topically active glucocorticoid from RPR shows potential for bronchial asthma

Oct. 24, 1997

Abbott develops inhibitors of LT biosynthesis

Oct. 24, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...